Propel Bio Management, LLC
38 holdingsFiling period: 2026-03-31Current AUM: $192.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | 1.27M | $30.2M | $32.7M | 17.05% | -- | 2026-03-31 |
| 2 | ACHV | ACHIEVE LIFE SCIENCES INC | 3.79M | $11.4M | $24.8M | 12.93% | -- | 2026-03-31 |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | 841.3K | $9.4M | $7.4M | 3.84% | -- | 2026-03-31 |
| 4 | DCTH | DELCATH SYS INC | 979.7K | $9.2M | $12.1M | 6.28% | -- | 2026-03-31 |
| 5 | CORT | CORCEPT THERAPEUTICS INC | 147.8K | $6.0M | $17.1M | 8.91% | -- | 2026-03-31 |
| 6 | ABEO | ABEONA THERAPEUTICS INC | 1.33M | $6.0M | $8.6M | 4.48% | -- | 2026-03-31 |
| 7 | VOR | VOR BIOPHARMA INC | 314.5K | $5.6M | $6.6M | 3.45% | -- | 2026-03-31 |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | 644.4K | $5.6M | $4.7M | 2.46% | -- | 2026-03-31 |
| 9 | MIST | MILESTONE PHARMACEUTICALS IN | 4.12M | $5.1M | $4.7M | 2.47% | -- | 2026-03-31 |
| 10 | CLDX | CELLDEX THERAPEUTICS INC NEW | 131.4K | $4.1M | $5.0M | 2.58% | -- | 2026-03-31 |
| 11 | CMPS | COMPASS PATHWAYS PLC | 742.0K | $4.1M | $8.4M | 4.40% | -- | 2026-03-31 |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | 210.2K | $4.1M | $4.0M | 2.06% | -- | 2026-03-31 |
| 13 | IVA | INVENTIVA SA | 724.7K | $4.0M | $3.2M | 1.68% | -- | 2026-03-31 |
| 14 | SABS | SAB BIOTHERAPEUTICS INC | 1.01M | $3.9M | $3.6M | 1.89% | -- | 2026-03-31 |
| 15 | OBIO | ORCHESTRA BIOMED HLDGS INC | 896.7K | $3.8M | $3.6M | 1.87% | -- | 2026-03-31 |
| 16 | FDMT | 4D MOLECULAR THERAPEUTICS IN | 380.4K | $3.6M | $3.9M | 2.04% | -- | 2026-03-31 |
| 17 | — | OCULIS HOLDING AG | 122.2K | $3.3M | $3.3M | 1.71% | -- | 2026-03-31 |
| 18 | OCUL | OCULAR THERAPEUTIX INC | 382.4K | $3.2M | $3.1M | 1.62% | -- | 2026-03-31 |
| 19 | UPB | UPSTREAM BIO INC | 341.8K | $3.1M | $2.2M | 1.13% | -- | 2026-03-31 |
| 20 | AQST | AQUESTIVE THERAPEUTICS INC | 711.0K | $3.0M | $2.6M | 1.37% | -- | 2026-03-31 |
| 21 | EYPT | EYEPOINT INC | 215.8K | $2.8M | $2.6M | 1.38% | -- | 2026-03-31 |
| 22 | TRVI | TREVI THERAPEUTICS INC | 223.8K | $2.6M | $4.0M | 2.11% | -- | 2026-03-31 |
| 23 | ZVRA | ZEVRA THERAPEUTICS INC | 282.4K | $2.6M | $2.7M | 1.40% | -- | 2026-03-31 |
| 24 | VTL | IMMUNIC INC | 2.34M | $2.6M | $2.6M | 1.36% | -- | 2026-03-31 |
| 25 | CHRS | COHERUS ONCOLOGY INC | 1.42M | $2.4M | $2.0M | 1.05% | -- | 2026-03-31 |
← Scroll →
Page 1 of 2